Directa Plus PLC - London-based producer of graphene nanoplatelets-based products for consumer and industrial use - Receives positive test result relating to the potential for absorption of its graphene nanoplatelets powder through human skin. Test showed that there is no absorption potential for Pure G+ product, taking the total number of positive in vitro test results to eight. Says successful results from in vitro tests of hypoallergenic, non-toxic products is vital for use in textile markets, where customers have to be certain of the safety of the apparel they produce and market.
Current stock price: 116 pence
Year-to-date change: up 42%
By Arvind Bhunjun; arvindbhunjun@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
Directa Plus (DCTA)